Abstract
Pelvic recurrent rectal cancer is still a challenging clinical problem, and patients generally have a dismal prognosis and a poor quality of life. Surgical resection represents the only potentially curative treatment; neoadjuvant treatments are presently being taken into consideration to increase the resectability rate and to improve long-term survival.
Lingua originale | English |
---|---|
pagine (da-a) | 152-162 |
Numero di pagine | 11 |
Rivista | Annals of Surgical Oncology |
Volume | 17 |
DOI | |
Stato di pubblicazione | Pubblicato - 2010 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
- Combined Modality Therapy
- Female
- Fluorouracil
- Follow-Up Studies
- Humans
- Leucovorin
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Pelvic Neoplasms
- Prognosis
- Rectal Neoplasms
- Retrospective Studies
- Surgical Procedures, Operative
- Survival Rate